Authors: Opal, SM Sypek, JP Keith, JC Schaub, RG Palardy, JE Parejo, NA

Citation: Sm. Opal et al., Evaluation of the safety of recombinant P-selectin glycoprotein ligand-immunoglobulin G fusion protein in experimental models of localized and systemic infection, SHOCK, 15(4), 2001, pp. 285-290

Authors: Opal, SM Palardy, JE Parejo, NA Creasey, AA

Citation: Sm. Opal et al., The activity of tissue factor pathway inhibitor in experimental models of superantigen-induced shock and polymicrobial intra-abdominal sepsis, CRIT CARE M, 29(1), 2001, pp. 13-17

Authors: Cross, AS Opal, SM Warren, HS Palardy, JE Glaser, K Parejo, NA Bhattacharjee, AK

Citation: As. Cross et al., Active immunization with a detoxified Escherichia coli J5 lipopolysaccharide group B meningococcal outer membrane protein complex vaccine protects animals from experimental sepsis, J INFEC DIS, 183(7), 2001, pp. 1079-1086

Authors: Simpson, AJH Opal, SM Angus, BJ Prins, JM Palardy, JE Parejo, NA Chaowagul, W White, NJ

Citation: Ajh. Simpson et al., Differential antibiotic-induced endotoxin release in severe melioidosis, J INFEC DIS, 181(3), 2000, pp. 1014-1019

Authors: Opal, SM Scannon, PJ Vincent, JL White, M Carroll, SF Palardy, JE Parejo, NA Pribble, JP Lemke, JH

Citation: Sm. Opal et al., Relationship between plasma levels of lipopolysaccharide (LPS) and LPS-binding protein in patients with severe sepsis and septic shock, J INFEC DIS, 180(5), 1999, pp. 1584-1589

Authors: Opal, SM Jhung, JW Keith, JC Goldman, SJ Palardy, JE Parejo, NA

Citation: Sm. Opal et al., Additive effects of human recombinant interleukin-11 and granulocyte colony-stimulating factor in experimental gram-negative sepsis, BLOOD, 93(10), 1999, pp. 3467-3472